SISTAM 2018 – Speakers

Last update: September, 23rd – 2018




Tony Hunter, Salk Institute for Biological Studies, San Diego, United States.

 New signal transduction targets in cancer therapy



Susan Taylor, University of California, San Diego, United States.

 Lessons Learned from PKA: From Molecule to Cells





Mario Amzel, Johns Hopkins School of Medicine, Baltimore, United States.

 Control of PIP3 levels by PI3Ka and PTEN



 Hellmut Augustin, Deutsches Krebsforschungszentrum, Heidelberg, Germany

 Molecular mechanisms of blood vessel maturation



Ricardo M. Biondi, Instituto de Investigación en Biomedicina de Buenos Aires (IBioBA) – CONICET – Partner Institute of the Max Planck Society, Buenos Aires, Argentina

 Small compounds and the allosteric communication between regulatory sites and the active site in protein kinases



Perry Blackshear, NIH Research Triangle Park, North Carolina, United States.

 No title provided yet



 Graciela Bocaccio, Fundación instituto Leloir, Buenos Aires, Argentina.

  Membrane-less organelles in translational regulation



 Ethel Cesarman, Weill Cornell Medical College, New York, United States.

 Viral pirating of cellular signals leading to cancer



 Robert Clarke, Manchester Breast Centre, Manchester, United Kingdom.

 Roles of stem cells in breast development and cancer progression and resistance to therapy



 Alejandro Colman Lerner, University of Buenos Aires, Buenos Aires, Argentina.

 Information processing in a cell fate decision system



Ruud Delwel, Erasmus University Medical Center, Rotterdam, The Netherlands.

 Enhancer defects in acute myeloid leukemia



Enrico Gratton, University of California. Irvine, United States.

 Deciphering molecular paths in the nucleus by 2-dimensional pair correlation functions



Gordon Hager, National Institutes of Health, Bethesda, United States.

 T Factor/Chromatin Interactions: The view from Genome-wide, Chromatin Biochemistry, and Live Cell Dynamics



Tracy Handel, University of California, San Diego, United States.

 What structure tells us about chemokine receptor activation and inhibition



Jonathan Lamarre, Ontario Veteninary College, Univ. of Guelph, Canada.

 Small RNA pathways in Developmental Signalling



Nathan Lawson, University of Massachusetts Medical School, Worcester, United States.

Genetic and chemical dissection of angiogenic signaling in the zebrafish



Ari Melnick, Weill Cornell Medical College, New York, United States.

 Mechanism and therapeutic targeting of the CARMA1-BCL10-MALT signaling complex



 Alexandra Newton, University of California, San Diego, United States.

 Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor



Guadalupe Sabio, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Spain.

 Adipose tissue, not only fat



Roger Sunahara, University of California, San Diego, United States.

 Allosterically Regulating G Protein-Coupled Receptors with G proteins, Small Molecules and Cations



Eldad Tzahor , Weizmann Institute, Rehovot, Israel

 Novel signaling mechanisms in heart regeneration



Karina Yaniv, Weizmann Institute, Rehovot, Israel

 Building blood and lymphatic vessels in health and disease